Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1973 2
1974 1
1975 2
1976 1
1978 4
1979 2
1980 3
1981 2
1982 2
1983 1
1984 7
1985 1
1987 4
1988 2
1989 3
1990 4
1991 8
1992 9
1993 8
1994 7
1995 6
1996 2
1997 5
1998 8
1999 5
2000 5
2001 3
2002 3
2003 6
2004 12
2005 12
2006 8
2007 6
2008 3
2009 6
2010 5
2011 8
2012 12
2013 13
2014 9
2015 10
2016 10
2017 12
2018 10
2019 12
2020 13
2021 13
2022 15
2023 11
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

292 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical Trial.
Piehl F, Eriksson-Dufva A, Budzianowska A, Feresiadou A, Hansson W, Hietala MA, Håkansson I, Johansson R, Jons D, Kmezic I, Lindberg C, Lindh J, Lundin F, Nygren I, Punga AR, Press R, Samuelsson K, Sundström P, Wickberg O, Brauner S, Frisell T. Piehl F, et al. Among authors: lindberg c. JAMA Neurol. 2022 Nov 1;79(11):1105-1112. doi: 10.1001/jamaneurol.2022.2887. JAMA Neurol. 2022. PMID: 36121672 Free PMC article.
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R; REGAIN Study Group. Howard JF Jr, et al. Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20. Lancet Neurol. 2017. PMID: 29066163 Clinical Trial.
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial.
Schoser B, Roberts M, Byrne BJ, Sitaraman S, Jiang H, Laforêt P, Toscano A, Castelli J, Díaz-Manera J, Goldman M, van der Ploeg AT, Bratkovic D, Kuchipudi S, Mozaffar T, Kishnani PS; PROPEL Study Group. Schoser B, et al. Lancet Neurol. 2021 Dec;20(12):1027-1037. doi: 10.1016/S1474-4422(21)00331-8. Lancet Neurol. 2021. PMID: 34800400 Clinical Trial.
Icon.
Lindberg C. Lindberg C. Stud Health Technol Inform. 2022 Feb 1;288:388-389. doi: 10.3233/SHTI211014. Stud Health Technol Inform. 2022. PMID: 35102858 No abstract available.
Positive deviance.
Lindberg C. Lindberg C. Am J Nurs. 2013 Dec;113(12):13. doi: 10.1097/01.NAJ.0000438850.74508.27. Am J Nurs. 2013. PMID: 24284567 No abstract available.
Inclusion body myositis.
Oldfors A, Lindberg C. Oldfors A, et al. Among authors: lindberg c. Curr Opin Neurol. 1999 Oct;12(5):527-33. doi: 10.1097/00019052-199910000-00006. Curr Opin Neurol. 1999. PMID: 10590889 Review.
Strategies for de-implementation of low-value care-a scoping review.
Ingvarsson S, Hasson H, von Thiele Schwarz U, Nilsen P, Powell BJ, Lindberg C, Augustsson H. Ingvarsson S, et al. Among authors: lindberg c. Implement Sci. 2022 Oct 27;17(1):73. doi: 10.1186/s13012-022-01247-y. Implement Sci. 2022. PMID: 36303219 Free PMC article. Review.
Measles: Still a Significant Health Threat.
Lindberg C, Lanzi M, Lindberg K. Lindberg C, et al. MCN Am J Matern Child Nurs. 2015 Sep-Oct;40(5):298-305; quiz E21-2. doi: 10.1097/NMC.0000000000000162. MCN Am J Matern Child Nurs. 2015. PMID: 26110575 Review.
292 results